Targeting NKT Cells and PD-L1 Pathway Results in Augmented Anti-Tumor Responses in a Melanoma Model
Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-010-0963-5
Full Text
Open PDFAbstract
Available in full text
Date
January 15, 2011
Authors
Publisher
Springer Science and Business Media LLC